Your browser doesn't support javascript.
loading
Re-administration of pembrolizumab with prednisolone after pembrolizumab-induced nephrotic syndrome.
Saito, Susumu; Kadota, Tsukasa; Gochi, Mina; Takagi, Masamichi; Kuwano, Kazuyoshi.
Afiliação
  • Saito S; Department of Respiratory Medicine, The Jikei University Kashiwa Hospital, Japan.
  • Kadota T; Department of Respiratory Medicine, The Jikei University Kashiwa Hospital, Japan; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Japan. Electronic address: tkskdt@jikei.ac.jp.
  • Gochi M; Department of Respiratory Medicine, The Jikei University Kashiwa Hospital, Japan.
  • Takagi M; Department of Respiratory Medicine, The Jikei University Kashiwa Hospital, Japan.
  • Kuwano K; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
Eur J Cancer ; 126: 74-77, 2020 02.
Article em En | MEDLINE | ID: mdl-31923730
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prednisolona / Adenocarcinoma / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Síndrome Nefrótica Tipo de estudo: Etiology_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prednisolona / Adenocarcinoma / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Síndrome Nefrótica Tipo de estudo: Etiology_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article